1. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
- Author
-
Furst, D.E., Keystone, E.C., Fleischmann, R., Mease, P., Breedveld, F.C., Smolen, J.S., Kalden, J.R., Braun, J., Bresnihan, B., Burmester, G.R., Benedetti, F. De, Dorner, T., Emery, P., Gibofsky, A., Kavanaugh, A., Kirkham, B., Schiff, M.H., Sieper, J., Singer, N., Riel, P.L.C.M. van, Weinblatt, M.E., Weisman, M.H., and Winthrop, K.
- Subjects
Immunoconjugates ,Tumor Necrosis Factor-alpha ,Immunology ,Antibodies, Monoclonal ,Antibodies, Monoclonal, Humanized ,Auto-immunity, transplantation and immunotherapy [N4i 4] ,General Biochemistry, Genetics and Molecular Biology ,Abatacept ,Antibodies, Monoclonal, Murine-Derived ,Rheumatology ,Evaluation of complex medical interventions [NCEBP 2] ,Antirheumatic Agents ,Rheumatic Diseases ,Immunology and Allergy ,Humans ,Health care ethics [NCEBP 5] ,Rituximab ,Immunosuppressive Agents - Abstract
Contains fulltext : 87536.pdf (Publisher’s version ) (Closed access) 01 januari 2010
- Published
- 2009